Chris Tyler

Chris Tyler

Chris Tyler, a Wall Street veteran of more than 20 years, began his career in the financial markets working on the trading floor of the AMEX in New York as an equity option market maker at Interactive Brokers’ floor trading unit Timber Hill LLC.

After moving to San Francisco to make markets on the P-Coast exchange during the dot-com craze and spending nearly a decade working in names like Philip Morris, Seagate and Compaq, Chris hung up his smock and trading badge, but not his passion for options and the markets.

Since exiting the floor, and for the better part of the past dozen years, Chris has worked as an option and market strategist, writing analyses for Trading Markets, Charles Schwab subsidiary Optionetics and as a featured columnist at Investor’s Business Daily.

Aside from offering his trading insights at InvestorPlace.com, Chris is currently studying for his Accredited Portfolio Management Advisor (APMA) designation, manages investments for closely held accounts and offers his services as an investment strategist to GLJ Advisors, a CA based RIA.

Chris, his wife and blue heeler live in the Pacific NW. And if you can’t follow him around in your own VW Vanagon or Westfalia, feel free to follow him on Twitter via @Options_CAT.

Recent Articles

It’s Time for Investors to Run Far Away From iBio Stock

Don’t let me talk you out of iBio stock, but a bit of skepticism is required given the massive hype behind this bio-pharmaceutical COVID-19 play.

Why Virus-Play CODX Stock Isn’t a Long-Term Cure for Ailing Portfolios

While doubts abound on the various economic interventions in play or in plan, the same can’t be said for coronavirus-play CODX stock.

3 Go-To Restaurant Stocks to Buy Now

The coronavirus is causing more people to stay home, and restaurants to close. However, these three restaurant stocks will thrive here.

At This Point, Ford Stock Isn’t Even Worth a Test Drive

Automaker Ford is one of the latest company’s taking preventative measures against COVID-19 and shares are getting hit. Still, the F stock price chart shows little reason to think a bottom is nearby

Where Growth Meets Value: 3 Stocks to Buy Amidst the Selloff

Keep a cool head, a watch list of stocks to buy and more importantly count the days to guard against entering a sick-looking market prematurely

Don’t Get Smoked by MO Stock’s Income Potential

MO stock has an attractive dividend and allure of being a safer investment, but that’s ignoring Altria's near three-year long bear market with no end in sight.

Zombies and Bears Beware, Alibaba Stock Will Still Defeat You!

A sick-looking market is even less healthy to kick off the week, but amid the panic, Alibaba stock remains a name to pick up on weakness.

Where and When to Shovel GDX into Your Portfolio

GDX hasn’t proven immune to the wrath of COVID-19, but there are good reasons beyond the selling pressure for investors to monitor shares for purchase

2 Stocks to Buy and 1 Stock to Sell for a Market Rebound

You can keep Apple or Microsoft on your trading screen, but these stocks to buy and sell may be more important in today’s bear market.

Don’t Get Suckered Into Trading Roku Stock

Roku stock hasn’t lived up to its promise as a COVID-19 play, but shares are still very much worth watching for longer-term growth investors